Transdermal selegiline is a monoamine oxidase inhibitor (MAOI) used as a treatment option for patients with treatment-resistant major depressive disorder (MDD). Why Transdermal Selegiline preferred…
Among the pharmacological options for MDD treatment, selegiline stands out, particularly in its transdermal form. Transdermal selegiline offers a novel approach to delivering this medication,…
Monoamine Oxidase Inhibitors (MAOIs) have not only shown efficacy with treatment resistant depression, but are also found efficacious for the treatment of depression in the…
Psychiatry Education Forum Academy has released the next clinically relevant discussion today, where Dr. Harvinder Singh has discussed the role of Transdermal Selegiline for depression…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
